There are currently 67 clinical trials in Temple, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including CCOP - Scott and White Hospital, Scott and White Memorial Hospital, Veterans Affairs Medical Center - Temple and Scott & White Memorial Hospital. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
NCT03678025
Recruiting
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Gender:
Male
Ages:
18 years and above
Trial Updated:
08/11/2023
Locations: Scott and White Memorial Hospital, Temple, Texas
Conditions: Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
Register for Updates
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
NCT04149743
Recruiting
Evaluation of the HEMOTAG® system in a less controlled environment and concurrently develop the system for use by patients with heart failure.
Gender:
All
Ages:
22 years and above
Trial Updated:
08/11/2023
Locations: Baylor Scott & White Research Institute, Temple, Texas
Conditions: Heart Failure (HF)
Register for Updates
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
NCT04091984
Recruiting
The ProActive registry is a longitudinal, multi-center study with a prospective arm observing clinical care for patients receiving physician ordered Prospera, an allograft rejection test, and a historical control arm collecting data on cases at the same sites whose kidney allograft rejection status was managed with Serum Creatinine SCr/estimated Glomerular Filtration Rate eGFR. This registry will compare patient management and outcomes in patients who receive Prospera (Prospera arm) to the outco... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/08/2023
Locations: Baylor Scott and White Research Institute, Temple, Texas
Conditions: Kidney Transplant Rejection
Register for Updates
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
NCT02781883
Recruiting
The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission [CR], Complete Remission with incomplete hematologic recovery [CRi], Complete Remission with partial hematologic recovery [CRh], than venetoclax plus decitabine alone (by historical comparison) in participants with untreated AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treat... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/27/2023
Locations: Baylor Scott & White Research Institute, Temple, Texas
Conditions: Acute Myeloid Leukemia (AML)
Register for Updates
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
NCT04089943
Recruiting
MicroRNA-210 (miR-210) can be a potential therapeutic target of patients with peripheral artery disease (PAD). Recent evidence suggests the role of miR-210 and oxidative stress in the pathophysiology of PAD and its association with mitochondrial function, oxidative metabolism, walking distances and quality of life. The protocol evaluates the mechanisms which miR-210 regulates oxidative stress and provides evidence of potential therapeutic strategies.
Gender:
All
Ages:
30 years and above
Trial Updated:
02/03/2023
Locations: Baylor Scott and White Hospital, Temple, Texas
Conditions: Peripheral Arterial Disease, Vascular Diseases, Peripheral, Arterial Occlusive Diseases, Atherosclerosis
Register for Updates
Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT05614986
Recruiting
This trail is for patients with mild cognitive impairment (MCI) who are receiving a transcatheter aortic valve replacement (TAVR). We will assess changes in neurocognition following TAVR with the 5 minute Montreal Cognitive Assessment (mini MoCA) when comparing pre procedure with post procedure assessments.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/07/2022
Locations: Baylor Scott & White Medical Center - Temple, Temple, Texas
Conditions: Mild Cognitive Impairment, Aortic Stenosis
Register for Updates
Virtual Reality Pain Study
NCT05293275
Recruiting
Investigating pain in hospitalized patients in two groups: virtual reality usage group vs standard of care
Gender:
All
Ages:
18 years and above
Trial Updated:
03/23/2022
Locations: Baylor Scott and White Hospital-Temple, Temple, Texas
Conditions: Hospitalized Patients 18 Years of Age or Older With Pain
Register for Updates